Last updated on March 2020

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)

Brief description of study

The reason for this long term study is to see how safe and effective the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE) who have completed the final treatment visit of study I4V-MC-JAHZ (NCT03616912) or study I4V-MC-JAIA (NCT03616964).

Clinical Study Identifier: NCT03843125

Find a site near you

Start Over

Vincent Pallotti Hospital

Cape Town, South Africa
  Connect »

Panorama Medical Centre

Cape Town, South Africa
  Connect »